Chronic inflammation isn't always a treatment issue — it's often a metabolic bottleneck most practitioners were never trained to identify.
If you've tried everything — diets, omega strategies, anti-inflammatory protocols — and still have patients who don't improve, the issue may not be your approach. It may be that your patient cannot produce the anti-inflammatory compounds required to resolve inflammation in the first place.
Medical training covers inflammation extensively — but almost never addresses the metabolic enzyme that determines whether your patient can actually resolve it. When this enzyme fails, every protocol downstream fails with it.
Delta-6 desaturase is the rate-limiting step in essential fatty acid metabolism. Aging, genetics, insulin resistance, and chronic illness can impair it — silently blocking your patient's ability to fight inflammation.
No matter how much omega-3, fish oil, or curcumin you give — if this enzyme isn't functioning, your patient physically cannot convert it to the anti-inflammatory compounds they need. The raw materials go in. Nothing useful comes out.
The result is treatment-resistant inflammation that erodes patient trust and practitioner confidence — not because of a bad protocol, but because of a metabolic bottleneck nobody identified.
The delta-6 desaturase pathway plays a critical role in converting essential fatty acids into anti-inflammatory compounds. When this pathway is impaired, inflammation cannot be properly resolved — regardless of treatment.
This is why some patients never respond. It's not a compliance issue. It's not a dosing issue. It's a conversion issue — and until you address it, nothing changes.
This is the problem: When delta-6 desaturase is impaired, everything downstream is compromised — regardless of omega-3 intake, diet changes, or supplementation.
EZtrek® is a patented medical food — not a supplement — formulated to deliver the downstream metabolites your patient's body can't produce on its own. It bypasses the impaired enzyme completely.
Delivers pre-formed GLA and other downstream metabolites that don't require delta-6 desaturase conversion
Provides the exact building blocks for anti-inflammatory eicosanoid production — the compounds your patient's body has been unable to make
Practitioners report measurable improvements in previously non-responsive cases — COPD, chronic pain, cardiovascular inflammation, and more
Full clinical protocols provided upon practitioner registration
When the underlying issue is impaired EFA metabolism, the clinical applications are broad — because inflammation touches everything.
These are real outcomes reported by practitioners — in cases where conventional approaches had already failed.
"54-yr-old female. History of smoking less than 1 pack a day for 20 years. Diagnosed with COPD 3 years ago. History of Covid-19, which caused damage to lungs. Pneumothorax with collapsed lung that required hospitalization. CT showed significant scarring. Pulmonologist was guarded on any improvement, stating, 'Your case is grim.' She has labored breathing and required 24-hour oxygen... (She has only been on EZtrek® for one month.) She no longer requires oxygen and can now speak and move about without being winded. Nothing else changed other than adding EZtrek®."
"Baseline non-contrast CT Agatston Score of 727 on 4/30/2021: Score reduced to 666 on 6/30/2022 [7 months taking EZtrek®]. This translates to an annualized calcified plaque reduction of 14.3%."
"85 years old. Diagnosable diseases are Dementia / Alzheimer's. She is completely immobile, and bed/wheelchair bound... She had rapidly declined since August of this year. Hospice accepted her...she had 6 months or less to live. [With EZtrek®] on December 23rd [4 months later]...they will remove her from the program, which is remarkable and encouraging! The only thing I have done is given her EZtrek®."
"86-year-old patient experienced a significant bilateral orbitofrontal and nasal crushing injury in a fall. Surprisingly had much less nasal injury than expected, including no fractured/comminuted nasal bones or orbital rim/floor fracture. Within 10 days, she demonstrated remarkable resolution of the facial edema and bruising... her overall recovery was unusually expedited and uncomplicated."
"...diagnosed with COPD over 10 years ago...stage 2. I also have a history of pneumonia over the years. I have been taking Albuterol for 10 years plus Symbicort and Prednisone... When I started EZtrek®, within an hour, I could actually feel my lungs opening. I am no longer using my Albuterol. I have more energy and am able to walk without being winded. My blood pressure is normal and pain has reduced completely."
"54-yr-old female with COPD and Covid-related lung damage. Pneumothorax with collapsed lung. CT showed significant scarring. Pulmonologist stated, 'Your case is grim.' Required 24-hour oxygen... After one month on EZtrek®, she no longer requires oxygen and can now speak and move about without being winded. Nothing else changed."
"85 years old with Dementia / Alzheimer's. Completely immobile, bed/wheelchair bound. Rapidly declined. Hospice accepted her...6 months or less to live. [4 months on EZtrek®] They will remove her from the program. The only thing I have done is given her EZtrek®."
"I'm curious about EZtrek®, which John has taken since his last appointment. Before his brain injuries, John was a very good writer. Since then, it's been a struggle. He recently wrote 3 separate things to family members, and I was amazed at what he said and how he said it."
"I have a patient taking EZtrek® for 1 month and her brain fog and mental clarity have greatly improved (a result of decreased inflammation of the brain). She has Epstein-Barr, hypothyroid, Lyme, and post-Covid fatigue. Nothing else changed other than adding EZtrek®."
"An elderly woman in her early 90's had been having absence seizure-like activity for many years and would only communicate intermittently... After 1 month of taking EZtrek®, the woman started to speak more spontaneously... She has maintained this improved behavior for many months. The absence seizure-like behavior has stopped."
"...knuckles and the swelling in her proximal interphalangeal and metacarpophalangeal joint of her hands and wrist were reduced by 75% since she has been taking 2 tsp of EZtrek® [morning / evening doses]..."
"I injured my back mid-2021... I started using EZtrek® and within 7 days the muscle inflammation in my back subsided to the point that I moved freely without concern."
"52-yr-old female. History of stage 4 breast cancer for 17 years. Mets to bone and liver. Chemo-induced neuropathy plus 3 years. She has been on EZtrek® for 3 weeks and is having less problems with pain from neuropathy. She reports more energy and feels stronger."
"92-year-old female fell - 3 fractures of hip: similar event 10 years prior. She had been taking EZtrek® for 6 months prior to falling. After 10 days skilled nursing, projected time to home using walker, was 6-8 weeks..."
"As a physician and surgeon personally using an oral preparation of the essential fatty acids per EZtrek® to facilitate treatment of inflammatory conditions (gout)... Since starting EZtrek® I have never had another gout attack."
"I've had the pt. on EZtrek® for 6 months. Since then, she has had no eczema flareups."
"Physician self-patient: I was suffering from total body eczema, some areas worse than others. I did a three-month treatment with EZtrek®, 2 teaspoons per day the first month, 1 daily dose months 2 and 3. My eczema is 90% resolved...."
"86-year-old patient experienced a significant bilateral orbitofrontal and nasal crushing injury in a fall. Surprisingly had much less nasal injury than expected, including no fractured/comminuted nasal bones. Within 10 days, remarkable resolution of facial edema and bruising. Her facial soft tissues and bones were more resilient and the bones also not brittle."
"...2 months ago, had 2 enlarged axillary lymph nodes, a swollen left breast duct, and 30% larger left breast. Today, there is excellent bilaterally equal and normal (healthy) texture of breast tissue, no lymph node enlargement or breast swelling. Only difference is that she has taken EZtrek®...."
"...3 high-sensitivity CRP tests conducted - June value was 1.4, mid-September was 1.8, and late November was 0.7. The 0.7 value [61% decrease] represents approximately 3 1/2 weeks of EZtrek® use."
"History of CHF, likely induced from Lyme, etc. Contributing is MTHFR. High-sensitivity CRP test went from 1.5 to 1.1. The 1.1 value [27% decrease] represents 4 weeks of EZtrek® use."
"(CHF patient) - Homocysteine decrease from 13 to 9 [31% decrease] after 4 weeks of EZtrek® use."
"72 y/o male with elevated PSA of 6.2 in 04/2021. Mold toxicity. 2 months with EZtrek®: rt posterior lesion shrunk from 0.9x0.7 cm to 0.7x0.6cm, a 33% decrease in area."
This isn't just a clinical tool — it's a practice differentiator. Practitioners implementing this approach are seeing benefits on both sides of their business.
Reach the patients who have been stuck — the chronic cases that haven't responded to anything else. When they finally improve, your reputation grows with every referral.
Offer something no one else in your area has — a patented medical food backed by real science that most practitioners have never even heard of. This is how you stand apart.
A clinically aligned revenue stream that doesn't require increasing patient volume — wholesale practitioner pricing with no minimum orders.
EZtrek® is a 30-day supply — and once patients experience results, most stay on it indefinitely. That's not a one-time sale. That's a recurring revenue line that grows as your patient base does.
Each bottle is a 30-day supply. Patients on maintenance don't stop — they reorder. That's predictable, recurring revenue from every patient you put on it.
The goal isn't a 90-day course — it's long-term metabolic support. Practitioners keep patients on EZtrek® indefinitely, which means the revenue compounds the longer your practice uses it.
Practitioner-only access means patients return to your practice every 30 days. It can't be found on Amazon, in a pharmacy, or at any retail store.
Have questions about the science, the mechanism, or how to apply EZtrek® in your most challenging cases? Book a complimentary 15-minute consultation directly with the creator of EZtrek® — a rare opportunity reserved for licensed practitioners.
World-leading researcher in essential fatty acids & metabolic inflammation. Creator of EZtrek® medical food. MIT-trained scientist and author.
With Prof. Brian Peskin — EZtrek® Creator
From doctors who were skeptical — until they saw what happened with their own patients
"This is the first intervention I've had for my most stubborn inflammation cases. Patients who weren't responding to anything are finally seeing improvement."
"I have been taking EZtrek® for one month. I have noticed that my energy has increased 30%, and mucous has subsided. I am putting my patients, as well as my children on the product."
"The mechanism is elegant — bypass the impaired enzyme, deliver what the body needs. Why didn't I think of this before?"
"I was skeptical at first, but the science made sense. Now it's a staple in my protocols for chronic inflammatory conditions."
Common questions from practitioners evaluating EZtrek®
Register as a practitioner in under 60 seconds. No cost, no obligation. Get wholesale access, full clinical protocols, and a tool for the cases nothing else has solved.
Access the Clinical Overview